Skip To Main Content

Effectiveness of a university on-campus pharmacist directed tobacco cessation program

Brittany L. Long, PharmD, TTS, Michael J. Rush PharmD, BCACP, CDE, TTS, Karen L Kier, PhD, MSc, RPh, BCPS,BCACP, TTS
Ohio Northern University
Institution if not ONU: 


Tobacco use continues to be a problem for adolescents and adults, occurring at high rates on college and university campuses. It is widely known that pharmacists can be successful and are well qualified to take part in the tobacco cessation process with patients, but most studies have researched their role in community pharmacy. The study purpose is to determine the effectiveness of a pharmacist-driven tobacco cessation program taking place on a university campus through an ambulatory health and wellness clinic for employees, dependents, and students. This is intended to fill the evidence gap for pharmacists in this unique environment.



The study is IRB approved. Current tobacco users (employees, dependents, or students older than 18) will be recruited to participate. At an initial pharmacist visit, data regarding tobacco use, past medical history, current medications, blood pressure, and demographics will be collected. An appropriate quit route of counseling alone or in conjunction with nicotine replacement or prescription medication will be established. Patient follow-up occurs on quit day, one, four, eight, and twelve weeks, post-treatment, and fourteen and thirty days post-treatment. Tobacco use will be assessed at each visit. Side effects and nicotine withdrawal will be assessed via Likert scale throughout end of treatment. Attitudes and beliefs will be assessed initially and at eight and twelve weeks via piloted survey. At minimum, blood pressure will be monitored with nicotine replacement at four and eight weeks. Program effectiveness is defined as no tobacco use during the two weeks after treatment end. Data will be de-identified, stored in a password-secured document, and protected through HIPAA standards. Visit forms, surveys, and assessments will be in the individual’s medical chart securely stored in the clinic. Descriptive and inferential statistics will be used to analyze data for all outcome variables. Data will be presented in aggregate form.




American Society of Health-System Pharmacists
PDF icon tcp_poster_final.pdf1.81 MB